Medscape7d
The Biology of Malignant Breast Tumors Has an Impact on the Presentation in Ultrasound
Precise evaluation of breast masses before further diagnostic or therapeutic steps has a crucial impact on the quality of the treatment and the outcome in the patient. Lesion assessment by ...
Pharmaceutical Technology8d
Ruxolitinib phosphate by Incyte for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome: Likelihood of Approval
CLL as first line therapy and breast biopsy showing ADH (atypical ductal hyperplasia), ALH (atypical lobular hyperplasia), LCIS (lobular carcinoma in situ), or DCIS (ductal carcinoma in situ), ...
Pharmaceutical Technology8d
Ruxolitinib phosphate by Novartis for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
CLL as first line therapy and breast biopsy showing ADH (atypical ductal hyperplasia), ALH (atypical lobular hyperplasia), LCIS (lobular carcinoma in situ), or DCIS (ductal carcinoma in situ), ...